Cargando…

Who benefits from R0 resection? A single-center analysis of patients with stage Ⅳ gallbladder cancer

OBJECTIVES: Most patients with gallbladder cancer (GBC) present with advanced-stage disease and have a poor prognosis. Radical resection remains the only therapeutic option to improve survival in patients with GBC. This study aimed to analyze the prognostic factors in patients with stage Ⅳ GBC and t...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Chen, Wang, Lin, Zhang, Rui, Li, Qi, Zhao, Ya-Ling, Zhang, Guan-Jun, Li, Wen-Zhi, Geng, Zhi-Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Chinese Medical Association 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6926113/
https://www.ncbi.nlm.nih.gov/pubmed/31891130
http://dx.doi.org/10.1016/j.cdtm.2019.08.004
_version_ 1783482031477358592
author Chen, Chen
Wang, Lin
Zhang, Rui
Li, Qi
Zhao, Ya-Ling
Zhang, Guan-Jun
Li, Wen-Zhi
Geng, Zhi-Min
author_facet Chen, Chen
Wang, Lin
Zhang, Rui
Li, Qi
Zhao, Ya-Ling
Zhang, Guan-Jun
Li, Wen-Zhi
Geng, Zhi-Min
author_sort Chen, Chen
collection PubMed
description OBJECTIVES: Most patients with gallbladder cancer (GBC) present with advanced-stage disease and have a poor prognosis. Radical resection remains the only therapeutic option to improve survival in patients with GBC. This study aimed to analyze the prognostic factors in patients with stage Ⅳ GBC and to identify a subgroup of patients who might benefit from R0 resection. METHODS: A total of 285 patients with stage Ⅳ GBC were retrospectively analyzed at our institution from January 2008 to December 2012. Factors potentially influencing the prognosis of GBC after surgery were analyzed by univariate and multivariate analyses. RESULTS: The 1-, 3-, and 5-year overall survival rates were 6.6% (15/229), 0.9% (2/229), and 0 (0/229), respectively. Ascites (relative risk [RR] = 1.631, 95% confidence interval [CI]: 1.221–2.180, P = 0.001), pathological grade (RR = 1.337, 95% CI: 1.050–1.702, P = 0.018), T stage (RR = 1.421, 95% CI: 1.099–1.837, P = 0.000), M stage (RR = 1.896, 95% CI: 1.409–2.552, P = 0.000), and surgery (RR = 1.542, 95% CI: 1.022–2.327, P = 0.039) were identified as independent risk factors influencing prognosis. The median survival time (MST) was significantly higher in patients undergoing R0 resection than in those undergoing R1/R2 resection (6.0 vs. 2.7 months; P < 0.001). In subgroup analyses, stage ⅣA patients benefited from R0 resection (MST for R0 vs. R1/R2, 11.0 vs. 4.0 months; P = 0.003), while R0 resection had a significant survival benefit than R1/R2 resection in patient with stage ⅣB GBC without distant metastasis (MST for R0 vs. R1/R2, 6.0 vs. 3.0 months; P = 0.007). CONCLUSION: Ascites, pathological grade, T stage, M stage, and surgery were independent risk factors influencing prognosis in patients with stage IV GBC. N2 lymph node metastasis did not preclude curative resection, and radical resection should be considered in patients with stage Ⅳ GBC without distant metastasis once R0 margin was achieved.
format Online
Article
Text
id pubmed-6926113
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Chinese Medical Association
record_format MEDLINE/PubMed
spelling pubmed-69261132019-12-30 Who benefits from R0 resection? A single-center analysis of patients with stage Ⅳ gallbladder cancer Chen, Chen Wang, Lin Zhang, Rui Li, Qi Zhao, Ya-Ling Zhang, Guan-Jun Li, Wen-Zhi Geng, Zhi-Min Chronic Dis Transl Med Original Article OBJECTIVES: Most patients with gallbladder cancer (GBC) present with advanced-stage disease and have a poor prognosis. Radical resection remains the only therapeutic option to improve survival in patients with GBC. This study aimed to analyze the prognostic factors in patients with stage Ⅳ GBC and to identify a subgroup of patients who might benefit from R0 resection. METHODS: A total of 285 patients with stage Ⅳ GBC were retrospectively analyzed at our institution from January 2008 to December 2012. Factors potentially influencing the prognosis of GBC after surgery were analyzed by univariate and multivariate analyses. RESULTS: The 1-, 3-, and 5-year overall survival rates were 6.6% (15/229), 0.9% (2/229), and 0 (0/229), respectively. Ascites (relative risk [RR] = 1.631, 95% confidence interval [CI]: 1.221–2.180, P = 0.001), pathological grade (RR = 1.337, 95% CI: 1.050–1.702, P = 0.018), T stage (RR = 1.421, 95% CI: 1.099–1.837, P = 0.000), M stage (RR = 1.896, 95% CI: 1.409–2.552, P = 0.000), and surgery (RR = 1.542, 95% CI: 1.022–2.327, P = 0.039) were identified as independent risk factors influencing prognosis. The median survival time (MST) was significantly higher in patients undergoing R0 resection than in those undergoing R1/R2 resection (6.0 vs. 2.7 months; P < 0.001). In subgroup analyses, stage ⅣA patients benefited from R0 resection (MST for R0 vs. R1/R2, 11.0 vs. 4.0 months; P = 0.003), while R0 resection had a significant survival benefit than R1/R2 resection in patient with stage ⅣB GBC without distant metastasis (MST for R0 vs. R1/R2, 6.0 vs. 3.0 months; P = 0.007). CONCLUSION: Ascites, pathological grade, T stage, M stage, and surgery were independent risk factors influencing prognosis in patients with stage IV GBC. N2 lymph node metastasis did not preclude curative resection, and radical resection should be considered in patients with stage Ⅳ GBC without distant metastasis once R0 margin was achieved. Chinese Medical Association 2019-10-21 /pmc/articles/PMC6926113/ /pubmed/31891130 http://dx.doi.org/10.1016/j.cdtm.2019.08.004 Text en © 2019 Chinese Medical Association. Production and hosting by Elsevier B.V. on behalf of KeAi Communications Co., Ltd. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Original Article
Chen, Chen
Wang, Lin
Zhang, Rui
Li, Qi
Zhao, Ya-Ling
Zhang, Guan-Jun
Li, Wen-Zhi
Geng, Zhi-Min
Who benefits from R0 resection? A single-center analysis of patients with stage Ⅳ gallbladder cancer
title Who benefits from R0 resection? A single-center analysis of patients with stage Ⅳ gallbladder cancer
title_full Who benefits from R0 resection? A single-center analysis of patients with stage Ⅳ gallbladder cancer
title_fullStr Who benefits from R0 resection? A single-center analysis of patients with stage Ⅳ gallbladder cancer
title_full_unstemmed Who benefits from R0 resection? A single-center analysis of patients with stage Ⅳ gallbladder cancer
title_short Who benefits from R0 resection? A single-center analysis of patients with stage Ⅳ gallbladder cancer
title_sort who benefits from r0 resection? a single-center analysis of patients with stage ⅳ gallbladder cancer
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6926113/
https://www.ncbi.nlm.nih.gov/pubmed/31891130
http://dx.doi.org/10.1016/j.cdtm.2019.08.004
work_keys_str_mv AT chenchen whobenefitsfromr0resectionasinglecenteranalysisofpatientswithstageivgallbladdercancer
AT wanglin whobenefitsfromr0resectionasinglecenteranalysisofpatientswithstageivgallbladdercancer
AT zhangrui whobenefitsfromr0resectionasinglecenteranalysisofpatientswithstageivgallbladdercancer
AT liqi whobenefitsfromr0resectionasinglecenteranalysisofpatientswithstageivgallbladdercancer
AT zhaoyaling whobenefitsfromr0resectionasinglecenteranalysisofpatientswithstageivgallbladdercancer
AT zhangguanjun whobenefitsfromr0resectionasinglecenteranalysisofpatientswithstageivgallbladdercancer
AT liwenzhi whobenefitsfromr0resectionasinglecenteranalysisofpatientswithstageivgallbladdercancer
AT gengzhimin whobenefitsfromr0resectionasinglecenteranalysisofpatientswithstageivgallbladdercancer